Amneal Pharmaceuticals

Globally, there is a shortage of this new class of diabetes and obesity treatment

The firm already has manufacturing units in four Indian cities, all of which are focused on the export market

US-based Amneal Pharmaceuticals Inc on Tuesday said it has acquired Ahmedabad-based drug firm Puniska Healthcare Pvt Ltd for a total value of around Rs 700 crore. The acquisition significantly enhances Amneal's injectables manufacturing infrastructure, capabilities, and capacity to support the US market and serve as a foundation for international markets, the company said in a statement. Puniska includes a 293,000 square foot, manufacturing facility in Ahmedabad, with a number of sterile injectable production lines. Production capabilities include robotic, aseptic and lyophilize vial lines, emulsion line, and large-volume parenteral bag line, it added. The acquisition also brings to the company approximately 550 Puniska employees with key capabilities in injectables manufacturing, R&D and commercialisation, Amneal said. "This acquisition is a pivotal step that meaningfully enhances our injectables capabilities for the US market and enables international expansion, including in ...

Amneal's EluRyng is the first generic version of this low competition drug, which the company plans to launch this month

Indo-American brothers Chirag and Chintu Patel have built a $1.8-bn drug giant that is set to pip Sun Pharma as the fifth largest generics maker in the US